FDA Inspection 629165 — Lions Eye Bank Of Nebraska

Lions Eye Bank Of Nebraska — FEI 3001456156

The FDA completed an inspection of Lions Eye Bank Of Nebraska on Nov 16, 2009 in Omaha, NE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 16, 2009
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Omaha, NE (United States)

Citations

IDCFRDescription
1233421 CFR 1271.170(c)Trained or re-trained as necessary
1233621 CFR 1271.180(a)Procedures to meet core CTGP
1239621 CFR 1271.225Approval and timely communication
1242921 CFR 1271.265(d)Shipping conditions appropriate

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.